- About RADICALS
- Information for Patients
- Information for participating and interested centres
- CCTG website for Canadian participants
- MRC CTU Contacts
- Useful links
RADICALS is a large clinical trial which is taking place in the UK, Canada, Denmark and the Republic of Ireland at the moment.
It is a phase III randomised controlled trial that will recruit approximately 3000 men to help answer two important questions for men who have had surgery for prostate cancer:
In breast cancer, surgery is followed by radiotherapy and hormone treatment, because the combination is better than surgery alone. In prostate cancer, surgery alone is a standard treatment, and we are not sure how best to use radiotherapy and hormone treatment after surgery.
The trial may be suitable at some point for most men who have a radical prostatectomy.
We are delighted to announce that RADICALS will be closing to recruitment on 30th December 2016! Thank you to everyone who has helped us throughout these years and enabling us to recruit >4000 patients!
I would also like to welcome Katherine Beaney as the RADICALS Data Manager at the MRC CTU.
We have some exciting and important updates which you can read about in the latest version of the RADICALS Newsletter. We hope you take a look and please feel free to get in touch if you have any comments or questions.
RADICALS-HD closed on 30th June 2015 with just under 3000 patients!
RADICALS-RT is still open to recruitment so please continue to support us.
We are pleased to say that we will continue recruting to both comparisons in RADICALS-HD until mid-2015 and possibly longer for RADICALS-RT (mid-2016).
Also, everyone should now have all the documents for the recently approved protocol amendment version 5.0
Princess Margaret Hospital in Toronto put in their 100th patient on 30th October 2013! Well done and congratulations for all your hard work! They now join Guy’s Hospital and Mount Vernon Hospital in London as the centres with more than 100 patients. We look forward to seeing this list grow.
We have reached a fantastic milestone in RADICALS-HD where we now have 1000 patients in each of the two RADICALS-HD comparisons (none vs short and short vs long). Our target accrual is at least 1370 patients in the none-vs-short comparison and at least 1130 patients in the short-vs-long comparison. Currently we have 1916 patients in RADICALS-HD overall and we are hoping to recruit an overall total in excess of 2500 patients, so, we still need everyone to keep up the great work and keep recruiting patients.